300 North Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-56,031
| Closed | -$2.23M | – | 73 |
|
|
2015
Q1 | $2.23M | Sell |
56,031
-2,429
| -4% | -$96.5K | 0.49% | 79 |
|
|
2014
Q4 | $1.31M | Buy |
+58,460
| New | +$1.31M | 0.3% | 86 |
|
|
2014
Q2 | – | Sell |
-51,189
| Closed | -$824K | – | 112 |
|
|
2014
Q1 | $824K | Buy |
51,189
+2,669
| +6% | +$43K | 0.21% | 84 |
|
|
2013
Q4 | $454K | Sell |
48,520
-3,700
| -7% | -$34.6K | 0.13% | 82 |
|
|
2013
Q3 | $591K | Buy |
+52,220
| New | +$591K | 0.14% | 103 |
|